Dietary Supplement and Nonprescription Drug Consumer Protection Act (S. 3546).

Summarizes provisions of S. 3546, the Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006, to require manufacturers of dietary supplements and over-the-counter drugs to report serious adverse events to the FDA, including deaths, birth defects, hospitalizations, incapacitation...

Full description

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 2006.
Series:	U.S. Congressional Research.
Subjects:	Death. Drugs. People with disabilities. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Summarizes provisions of S. 3546, the Dietary Supplement and Nonprescription Drug Consumer Protection Act of 2006, to require manufacturers of dietary supplements and over-the-counter drugs to report serious adverse events to the FDA, including deaths, birth defects, hospitalizations, incapacitations, or life-threatening experiences resulting from the use of nonprescription drugs or supplements.
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource.
Physical Description:	1 online resource.